ArticleInternational journal of clinical pharmacy2017

Use patterns of first-line inhibitors of tyrosine kinase and time to change to second-line therapy in chronic myeloid leukemia.

Jorge Enrique Machado-Alba et al.PubMed ↗Publisher ↗

No numbers read from the abstract.